Skip to main content

Table 1 Baseline characteristics of the patients

From: Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure

Age, years

70.5 (67–76)

Male, (%)

86 (63.2)

Previous stroke, (%)

53 (39.0)

Previous bleeding, (%)

64 (47.1)

Hypertension, (%)

49 (36.0)

Congenital heart disease, (%)

3 (2.2)

Diabetes mellitus, (%)

50 (36.8)

Cardiomyopathy, (%)

1 (0.7)

Heart failure, (%)

26 (19.1)

CHA2DS2-VASc score

4.4 (3.6–6)

HAS-BLED score

3 (3–4)

LAA electrical isolation, (%)

17 (12.5)

Electrical cardioversion, (%)

11 (8.1)

Embolic protection device, (%)

47 (34.6)

Types of AF

 Paroxysmal AF, (%)

20 (14.7)

 Persistent AF, (%)

43 (31.6)

 Permanent AF, (%)

73 (53.7)

Types of LAAC devices

 Watchman, (%)

12 (8.8)

 Watchman FLX, (%)

15 (11.0)

 ACP, (%)

29 (21.3)

 Amulet Amplatzer, (%)

66 (48.5)

 LAmbre, (%)

14 (10.3)

  1. ACP Amplatzer cardiac plug, AF atrial fibrillation, CHA2DS2-VASc, congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke, vascular disease, age 65–74 years, sex category, HAS-BLED hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs/alcohol concomitantly, LAA left atrial appendage, LAAC left atrial appendage closure
  2. Continuous data are summarized as n (%) or median (interquartile range)
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us